Ledger.Open graph →

SEC Form D · Amendment · filed March 31, 2021

Reprise Biomedical, Inc

Offering

$5.0M

Sold

$5.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Plymouth, MN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Erwin Kelen · PLYMOUTH, MNDirector Ronald Eibensteiner · PLYMOUTH, MNDirector Howard Root · PLYMOUTH, MNExec · Director Carrie Powers · PLYMOUTH, MNExec · Director Jeff Ross · PLYMOUTH, MNDirector Alex Thompson · Provo, UTExec · Director Daniel Auerbach · South San Francisco, CADirector Peter Morrow · San Diego, CADirector Andrew Carey · Sacramento, CADirector Paul H. Sartori · Charlottesville, VAExec · Director Thomas Pace · Austin, TXExec · Director Anne Marie Morley · CHICAGO, ILExec · Director Stephen Swanson · CHICAGO, ILDirector Zia Rahman · Alpharetta, GADirector Parth Munshi · Alpharetta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗